AFT Pharmaceuticals Limited logo

Issue of ordinary shares

Capital Change1 July 2020AFTHealthcare

Capital Change Notice


2 July 2020


Issue of ordinary shares


This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in

AFT Pharmaceuticals Limited.


Section 1: Issuer information

Name of issuer AFT Pharmaceuticals Limited

NZX ticker code AFT

Class of financial product Ordinary shares

ISIN (If unknown, check on NZX website) NZAFTE0001S4

Currency NZD

Section 2: Capital change details

Number issued 533,333

Nominal value (if any) Not applicable

Issue price per security $3.75

Nature of the payment Cash

Amount paid up (if not in full) Fully paid

Percentage of total class of Financial Products issued

(calculated on the number of Financial Products of the

Class, excluding any Treasury Stock, in existence)

0.517%

For an issue of Convertible Financial Products or

Options, the principal terms of Conversion

Not applicable

Reason for issue and specific authority for issue Allotment of 533,333 ordinary shares

under a share purchase plan

conducted by AFT Pharmaceuticals

Limited.

Total number of Financial Products of the Class after

the issue (excluding Treasury Stock) and the total

number of Financial Products of the Class held as

Treasury Stock after the issue.

103,701,049

Specific authority for the issue, including a reference

to the rule pursuant to which the issue is made

Authorised by a directors’ resolution.

The share purchase plan is made

pursuant to NZX Listing Rule 4.3.1(c)

(as modified by a class waiver granted

by NZX Regulation on 19 March 2020).

Terms or details of the issue (for example: restrictions,

escrow arrangements)

The ordinary shares issued rank pari

passu with the existing ordinary shares.

Date of issue 02/07/2020
Section 3: Authority for this announcement and contact person

Name of person


authorised to make this

announcement

Malcolm Tubby

Contact person for this announcement Malcolm Tubby

Contact phone number +64 9 488 0232

Contact email address malcolm.tubby@aftpharm.com

Date of release through MAP


02/07/2020

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • ATM — The a2 Milk Company Limited: Capital Change Notice
    2020-08-21

    Capital Change Notice Updated as at 17 October 2019 Notice of issue of Ordinary Shares This notice is given under the NZX Listing Rules 3.13.1 and 3.15.2 and relates to the exercise of options to subscribe for fully paid ordinary shares under ATM’s Long Term Incentive…”

  • ATM — The a2 Milk Company Limited: Capital Change Notice
    2020-08-19

    Capital Change Notice Updated as at 17 October 2019 Notice of issue of Ordinary Shares This notice is given under the NZX Listing Rules 3.13.1 and 3.15.2 and relates to the exercise of options to subscribe for fully paid ordinary shares under ATM’s Long Term Incentive…”

  • ATM — The a2 Milk Company Limited: Capital Change Notice
    2020-08-03

    Capital Change Notice Updated as at 17 October 2019 3 August 2020 Notice of issue of Ordinary Shares and rights This notice is given under NZX Listing Rule 3.13.1 and 3.15.2 and relates to the automatic exercise of time- based rights. Section 1: Issuer informatio…”